Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report

被引：0
|
作者：
Danielle Delombaerde
Delphine Vervloet
Dieter Berwouts
Roel Beckers
Hans Prenen
Marc Peeters
Félix Gremonprez
Lieselot Croes
Christof Vulsteke
机构：
[1] AZ Maria Middelares,Integrated Cancer Center Ghent, Department of Medical Oncology
[2] University of Antwerp,Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON)
[3] AZ Maria Middelares,Department of Cardiology
[4] AZ Maria Middelares,Department of Nuclear Medicine
[5] AZ Maria Middelares,Department of Radiology
[6] Antwerp University Hospital,Multidisciplinary Oncologic Centre Antwerp (MOCA)
来源：
Journal of Medical Case Reports | / 16卷
关键词：
Myocarditis; Immune-related adverse events; Dual checkpoint inhibition; Cholangiocarcinoma; Case report;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Clinical characteristics, diagnosis and management of nivolumab-induced myocarditis
    Li, Meng-Ting
    He, Yang
    Huang, Si-Yong
    Hu, Xiao
    Chen, Ji-Sheng
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (01) : 116 - 126
  • [42] Nivolumab-Induced Recurrence of Rheumatoid Arthritis in a Patient with Metastatic Gastric Adenocarcinoma
    Masataka Nishikawa
    Atsushi Goshima
    Hajime Owaki
    Takeshi Fuji
    Clinical Drug Investigation, 2019, 39 : 1251 - 1254
  • [43] Nivolumab-induced myocarditis complicated by complete atrioventricular block in a patient with metastatic non-small cell lung cancer
    Tan, Jin Lin
    Mugwagwa, Augustine Nyasha
    Cieslik, Luke
    Joshi, Rohit
    BMJ CASE REPORTS, 2019, 12 (07)
  • [44] Clinical and dermoscopical presentation of nivolumab-induced pemphigoid in a metastatic melanoma patient
    Chersi, Filippo
    Conforti, Claudio
    Zalaudek, Iris
    Bazzacco, Giulia
    Zelin, Enrico
    di Meo, Nicola
    MELANOMA RESEARCH, 2023, 33 (03) : 262 - 263
  • [45] NIVOLUMAB-INDUCED THYROID STORM AND CARDIOGENIC SHOCK IN A PATIENT WITH METASTATIC MELANOMA
    Roy, Sumon
    Goswamy, Vinay
    Singh, Harinder
    Portales, Ignacio
    Sheppard, Todd
    Feitell, Scott
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 2389 - 2389
  • [46] Clinical characteristics, diagnosis and management of nivolumab-induced myocarditis
    Meng-Ting Li
    Yang He
    Si-Yong Huang
    Xiao Hu
    Ji-Sheng Chen
    Investigational New Drugs, 2024, 42 : 116 - 126
  • [47] Nivolumab-induced myasthenia gravis in a patient with squamous cell lung carcinoma Case report
    Chen, Yu-Hsiu
    Liu, Feng-Cheng
    Hsu, Chang-Hung
    Chian, Chih-Feng
    MEDICINE, 2017, 96 (27)
  • [48] A Case of Nivolumab-Induced Myositis
    Fox, Eric
    Dabrow, Michael
    Ochsner, Greg
    ONCOLOGIST, 2016, 21 (12): : E3 - E3
  • [49] Reintroduction of nivolumab in a patient with gastric cancer after improvement of nivolumab-induced acute interstitial nephritis: a case report
    Hu, Qingjiang
    Hasuda, Hirofumi
    Ueki, Kenji
    Tsuchimoto, Akihiro
    Zaitsu, Yoko
    Tsuda, Yasuo
    Hisamatsu, Yuichi
    Nakashima, Yuichiro
    Ando, Koji
    Kimura, Yasue
    Oki, Eiji
    Mori, Masaki
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2020, 9 (03) : 127 - 132
  • [50] Reintroduction of nivolumab in a patient with gastric cancer after improvement of nivolumab-induced acute interstitial nephritis: a case report
    Qingjiang Hu
    Hirofumi Hasuda
    Kenji Ueki
    Akihiro Tsuchimoto
    Yoko Zaitsu
    Yasuo Tsuda
    Yuichi Hisamatsu
    Yuichiro Nakashima
    Koji Ando
    Yasue Kimura
    Eiji Oki
    Masaki Mori
    International Cancer Conference Journal, 2020, 9 : 127 - 132
12345